YOLFTbeta
00

Yifan Xinfu Pharmaceutical Co Ltd

002019 · SHE · Healthcare / Drug Manufacturers - General

8.91CNY-0.32 (-3.47%)

Price History

Full chart

Market Stats

Previous Close9.23
Open9.25
Day Range8.90 – 9.26
52-Week Range9.07 – 14.59
Volume18.09M
Market Cap11.46B
P/E (TTM)37.68
Forward P/E212.77
EPS0.25
Dividend Yield1.06%
Beta0.45
50-Day Avg9.93
200-Day Avg11.26

About

Yifan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products, vitamins, and polymer materials in China, South Korea, the Philippines, Vietnam, Italy, Thailand, and internationally. It offers pharmaceutical products, such as biopharmaceuticals, chemical drugs, and traditional Chinese medicines; vitamin products, including vitamin B5 and provitamin B5; and active pharmaceutical ingredients. The company was formerly known as Yifan Xinfu Pharmaceutical Co., Ltd. and changed its name to Yifan Pharmaceutical Co., Ltd. in October 2016. Yifan Pharmaceutical Co., Ltd. was founded in 2000 and is headquartered in Hangzhou, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • CEOMr. Xian Feng Cheng
  • Employees4.18K
  • HeadquartersNo. 50, Qinshan, Hangzhou, China, 311300, China
  • Websitehttps://www.yifanyy.com

Leadership

  • Mr. Xian Feng ChengChairman of the Board of Directors, President & GM · b. 1968
  • Mr. Dawei ZhangVP & CFO · b. 1981
  • Mr. Feng WangExecutive President · b. 1973
  • Ms. Li Ping QianExecutive President · b. 1983
  • Mr. Deqi FengBoard Secretary, Deputy GM, VP & Director · b. 1979
  • Mr. Ximing LiDeputy GM & VP · b. 1961
  • Ms. Yuhong GengDeputy GM & VP · b. 1971
  • Kai WangHead of Accounting
  • Mr. William TanDirector of Sales Team

Financials

Income Statement

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue91.34M130.95M176.77M245.06M269.31M346.40M764.74M479.92M405.99M379.88M495.73M644.19M1.16B1.68B2.43B3.50B4.37B4.63B5.19B5.40B4.41B3.84B4.07B5.16B5.13B
Growth (%)-+43.37%+34.99%+38.63%+9.90%+28.62%+120.77%-37.24%-15.41%-6.43%+30.50%+29.95%+79.79%+45.48%+44.51%+43.93%+24.79%+5.91%+11.98%+4.12%-18.36%-12.98%+6.03%+26.84%-0.52%
Cost of Revenue54.82M87.71M121.15M164.22M188.73M224.95M275.53M278.05M270.40M280.58M386.73M497.41M796.54M1.01B1.46B1.74B1.88B2.59B2.81B2.90B2.59B1.98B2.16B2.81B2.73B
Gross Profit36.51M43.24M55.62M80.84M80.59M121.45M489.21M201.87M135.58M99.30M109.00M146.78M361.67M672.79M973.26M1.77B2.50B2.04B2.38B2.50B1.81B1.85B1.91B2.35B2.41B
Gross Margin39.98%33.02%31.47%32.99%29.92%35.06%63.97%42.06%33.40%26.14%21.99%22.79%31.23%39.93%39.97%50.43%57.09%44.04%45.84%46.31%41.16%48.30%46.93%45.59%46.88%
Operating Expense10.84M18.26M26.12M39.37M41.88M107.73M116.53M146.28M105.53M286.19M339.12M126.06M207.68M373.50M596.07M881.06M990.14M1.15B1.30B1.42B1.60B1.71B2.79B1.97B1.83B
Operating Income25.67M24.98M29.50M41.47M38.71M13.72M372.69M55.60M30.05M-186.89M-230.12M20.73M154.00M299.29M377.20M886.46M1.51B891.12M1.08B1.08B212.20M143.81M-882.71M381.81M577.24M
Operating Margin28.11%19.08%16.69%16.92%14.37%3.96%48.73%11.58%7.40%-49.20%-46.42%3.22%13.30%17.76%15.49%25.29%34.45%19.24%20.75%20.08%4.81%3.75%-21.70%7.40%11.25%
EBITDA26.97M31.64M49.77M64.47M64.40M54.98M397.94M106.58M73.87M12.84M-159.38M72.06M160.23M326.18M453.15M1.02B1.69B1.07B1.22B1.19B453.82M379.13M253.66M642.69M825.51M
EBITDA Margin29.53%24.16%28.16%26.31%23.91%15.87%52.04%22.21%18.20%3.38%-32.15%11.19%13.83%19.36%18.61%29.22%38.74%23.20%23.50%22.05%10.29%9.88%6.24%12.46%16.08%
Net Income24.72M26.07M25.88M32.52M20.48M8.73M240.19M41.24M30.37M-197.55M-230.29M14.32M117.65M237.91M360.57M704.76M1.31B737.44M903.47M968.39M278.40M191.22M-551.07M385.97M402.02M
Net Income Margin27.07%19.91%14.64%13.27%7.60%2.52%31.41%8.59%7.48%-52.00%-46.45%2.22%10.16%14.12%14.81%20.11%29.84%15.92%17.42%17.93%6.31%4.98%-13.55%7.48%7.83%
R&D---------26.16M40.24M19.26M7.99M20.13M40.66M105.25M141.23M167.02M208.49M325.34M196.64M190.20M312.38M444.63M291.37M
R&D as % of Total Revenue---------6.89%8.12%2.99%0.69%1.19%1.67%3.00%3.23%3.61%4.02%6.02%4.46%4.96%7.68%8.62%5.68%
Interest Expense1.65M1.77M3.28M1.43M6.16M12.50M20.21M13.10M7.04M16.29M29.05M32.12M28.18M5.36M23.31M56.18M90.66M63.89M72.99M75.53M79.76M93.81M86.46M78.87M53.04M
Interest Expense % of Total Revenue1.80%1.35%1.85%0.58%2.29%3.61%2.64%2.73%1.73%4.29%5.86%4.99%2.43%0.32%0.96%1.60%2.07%1.38%1.41%1.40%1.81%2.45%2.13%1.53%1.03%

Balance Sheet

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets87.37M131.96M199.04M358.70M516.94M592.38M884.42M856.27M1.14B1.20B1.17B1.06B673.14M3.33B4.55B6.98B8.77B9.77B11.07B11.71B12.17B12.54B11.50B12.29B12.85B
Total Liabilities35.05M52.53M104.73M48.72M196.02M267.92M335.87M285.39M227.31M497.79M696.73M580.73M288.20M791.21M1.67B3.08B1.99B2.89B3.24B2.99B3.39B3.40B3.24B3.86B4.13B
Total Equity52.31M79.43M94.31M309.98M320.09M324.46M548.55M570.87M913.15M695.60M466.52M480.81M385.86M2.54B2.86B3.52B6.47B6.62B7.50B8.43B8.54B8.81B8.28B8.52B8.83B
Cash14.15M21.42M8.64M101.61M46.49M69.62M96.33M51.06M228.48M156.13M145.08M125.85M158.09M277.71M332.22M729.49M1.31B1.63B1.52B1.32B1.34B1.14B698.37M889.39M732.97M
Total Debt29.38M44.38M80.38M23.00M143.00M218.00M209.00M225.00M170.00M430.00M466.00M455.66M416.67M290.83M766.85M1.40B878.13M1.34B1.87B1.71B1.83B1.59B1.47B1.74B-
Net Debt15.23M22.96M71.74M-78.61M96.51M148.38M112.67M173.94M-58.48M273.87M320.92M329.81M258.58M13.12M434.63M671.64M-430.73M-289.58M344.72M389.58M489.24M446.34M774.75M846.00M1.33B

Cash Flow

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--12.65M33.59M24.12M32.62M248.71M83.31M58.61M-33.82M-52.82M29.88M34.32M139.74M401.96M855.85M1.13B1.17B937.24M1.11B301.23M472.07M348.58M640.73M458.37M
Investing Cash Flow---49.28M-85.03M-132.75M-67.24M-182.63M-113.70M-141.00M-266.38M-53.46M66.20M-60.90M-35.17M-827.91M-1.03B-1.56B-616.53M-1.59B-770.55M-507.89M-670.17M-532.84M-544.88M-
Financing Cash Flow--23.84M126.92M71.02M57.74M-39.36M-16.38M246.94M227.77M88.04M-155.56M1.04M6.99M413.93M664.27M1.08B-246.72M151.09M-567.95M222.16M-12.66M30.78M112.73M-
Capital Expenditure0052.44M70.14M58.63M57.62M172.06M122.46M151.27M199.32M99.74M67.64M73.95M89.51M217.15M287.50M485.86M729.21M866.07M715.71M571.74M542.27M504.09M628.16M559.23M
Free Cash Flow---39.78M-36.55M-34.51M-25.01M76.64M-39.15M-92.66M-233.15M-152.56M-37.76M28.10M50.23M184.81M568.34M646.87M441.69M71.17M392.80M-270.51M-70.21M-155.50M12.57M-100.87M
Dividends Paid--15.58M3.50M16.65M20.30M30.36M32.38M29.08M38.73M27.96M32.22M1.96M6.23M65.39M96.71M176.37M543.45M120.70M201.98M138.39M86.38M72.47M194.81M171.58M
FCF to OCF---314.36%-108.83%-143.06%-76.67%30.82%-46.99%-158.08%689.28%288.82%-126.36%81.88%35.94%45.98%66.41%57.11%37.72%7.59%35.43%-89.80%-14.87%-44.61%1.96%-22.01%
Dividend Paid to FCF---39.17%-9.57%-48.25%-81.19%39.61%-82.72%-31.38%-16.61%-18.33%-85.32%6.97%12.41%35.38%17.02%27.27%123.04%169.60%51.42%-51.16%-123.04%-46.60%1549.36%-170.10%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013May 28, 2014Jul 30, 2014Oct 26, 2014Jan 31, 2015Apr 24, 2015Aug 24, 2015Oct 28, 2015Feb 29, 2016Apr 22, 2016Aug 20, 2016Oct 26, 2016Feb 28, 2017Apr 26, 2017Aug 28, 2017Oct 29, 2017Apr 27, 2018Aug 29, 2018Oct 25, 2018Feb 27, 2019Apr 25, 2019Aug 26, 2019Oct 24, 2019Feb 28, 2020Apr 29, 2020Aug 30, 2020Oct 29, 2020Apr 28, 2021Aug 29, 2021Oct 29, 2021Apr 28, 2022Aug 30, 2022Oct 28, 2022Apr 28, 2023Aug 29, 2023Oct 30, 2023Apr 23, 2024Aug 14, 2024Oct 30, 2024Apr 27, 2025Aug 15, 2025Oct 31, 2025Apr 24, 2026Jun 30, 2026
EPS Estimate-------------------0.18-0.120.090.12---0.120.120.120.12----------------------------
EPS Actual0.01-0.02-0.01-0.34-0.01-0.01-0.00-0.380.030.02-0.01-0.020.010.010.010.020.070.130.050.140.080.080.110.060.120.210.160.060.060.060.060.270.180.140.020.120.280.210.130.260.310.160.110.060.070.100.030.03-0.030.040.03-0.570.090.090.020.120.070.010.08
Surprise--------------------22.22%--33.33%22.22%-50.00%----50.00%-50.00%-50.00%-50.00%----------------------------
Timing-----------------After-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market----

Key Statistics & Ratios

Market Cap11.46B
Enterprise Value13.20B
Trailing P/E37.68
Forward P/E212.77
PEG Ratio0.35
Price / Sales2.31
Price / Book1.31
EPS0.25
Book Value8.53
Revenue (TTM)4.97B
Gross Profit (TTM)2.23B
EBITDA680.97M
Profit Margin6.11%
Operating Margin11.04%
Return on Equity3.19%
Return on Assets1.72%
Shares Outstanding1.22B
Shares Float508.36M
Beta0.45
Dividend Yield1.06%
Dividend Rate0.10
Payout Ratio61.88%

Dividends

20261×
0.10May 29, 2026
20251×
0.10May 29, 2025
20241×
0.10Sep 25, 2024
20211×
0.05May 17, 2021
20201×
0.10May 26, 2020
20191×
0.10May 9, 2019
20182×
0.30Sep 26, 20180.10May 3, 2018
20171×
0.10Apr 28, 2017
20161×
0.04May 16, 2016
20151×
0.04Sep 25, 2015
20101×
0.04May 20, 2010
20091×
0.04May 15, 2009
20081×
0.04May 28, 2008
20071×
0.03May 18, 2007
20061×
0.02Jul 17, 2006
20051×
0.01Apr 7, 2005

Stock Splits

  • May 16, 201625:10
  • Aug 28, 200720:10
  • May 18, 20071.4:1
  • Aug 12, 200514.5:10
  • Apr 7, 200513:10